Biovault operates within one of the most strictly regulated data environments in UK healthcare. Because we process and store human cells and tissue for clinical therapies and partner directly with the NHS, our approach to data security goes far beyond standard GDPR compliance to reflect the profound clinical sensitivity of the information we handle.
navigating overlapping (and conflicting) regulatory frameworks
Maintaining complete data integrity across advanced therapies requires us to work within a complex matrix of regulatory and accreditation frameworks. At Biovault, our operations align with standards set by the Human Tissue Authority (HTA), the Medicines and Healthcare products Regulatory Agency (MHRA), and the Human Fertilisation and Embryology Authority (HFEA), alongside JACIE accreditation requirements and the NHS Data Security and Protection Toolkit (DSPT).
Navigating these overlapping requirements demands deep specialist expertise, particularly where distinct legal obligations intersect. The NHS DSPT (an online self-assessment for organisations handling NHS patient data) serves as an essential benchmark, providing continuous reassurance to our clinical and NHS partners that robust data security and privacy measures are strictly enforced.
Managing these intersections requires a precise understanding of regulatory priorities. For example, while UK GDPR provides a general right to erasure, this right is not absolute. Certain records may need to be retained where continued processing is necessary to meet applicable legal, regulatory, clinical or traceability requirements. Understanding how these frameworks interact is essential to maintaining compliance, robust data security, and the absolute integrity of the clinical record.
building a defense-in-depth data architecture
To protect data across a product’s entire lifecycle, Biovault employs a multi-layered defence-in-depth strategy. We integrate strict regulatory alignment, secure system design, and audited vendor selection into every workflow.
6 Key pillars of Biovault’s data security model
Centralised LIMS control: At the heart of our operations is a bespoke Laboratory Information Management System (LIMS). It enforces strict access permissions and maintains a complete, real-time audit trail for all data access and activity.
Annual NHS DSPT validation: Annual NHS DSPT assessments provide assurance against NHS data-security standards, underpinning the high level of security required for direct NHS partnership.
Cyber Essentials Plus infrastructure: We partner exclusively with IT suppliers who meet Cyber Essentials Plus standards, ensuring a resilient baseline that protects our network against modern cyber threats.
Expert regulatory prioritisation: Where regulatory frameworks intersect, our protocols ensure safety-critical laws are correctly upheld.
Transparent stakeholder communication: When communicating with our direct-to-market clients, we utilise fully GDPR-compliant platforms like Brevo. This guarantees lawful data use, clear consent management, and accessible opt-out options for all mailings.
Data assurance for advanced therapies: By embedding security into every layer of our digital and physical infrastructure, Biovault ensures that sensitive clinical and biological data remains fully protected, traceable, and compliant from initial processing through long-term storage.
Partnering with a trusted data custodian
In advanced therapies and biobanking, digital security is just as critical as physical cold-chain integrity. A single lapse in data governance or traceability can derail clinical trials, compromise patient privacy, and stall regulatory approval. By embedding clinical-grade data protection into every level of our operations, Biovault provides partners with complete confidence that their data is as secure as their samples.
Whether you are launching a new clinical trial, seeking an accredited tissue processing partner, or navigating complex HTA and GDPR requirements, Biovault Technical offers the regulatory expertise and LIMS infrastructure your program demands.
Contact our technical team today to discuss how our data governance framework can support and protect your advanced therapy pipeline.